MASIMO CORPORATION for MASIMO CORPORATION
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; Fiscal Year 2021 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids; COVID-19 Response Efforts and patient monitoring; CARES Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE MEIER | — |
| PAUL ORDAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.